Oncolytic immunoactivation associates with survival in a glioblastoma clinical trial
- PMID: 37941468
- PMCID: PMC10836764
- DOI: 10.1093/neuonc/noad216
Oncolytic immunoactivation associates with survival in a glioblastoma clinical trial
References
-
- Orvedahl A, Alexander D, Talloczy Z, et al. . HSV-1 ICP345 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe. 2007;1(1):23–35. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
